Page 11 - Genetic Testing News Today

Explore the facilitation of novel therapy access for desmoid tumors and discover emerging treatments reshaping the landscape.

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

Discover how medical institutions provide education on desmoid tumors, ensuring patient referrals and expanding access to innovative therapies.

Genetic testing for APOE would improve the prediction of atherosclerosis and enable the pursuit of aggressive strategies, said one researcher.

It's having trouble getting its core business model to work.

As leaders in the healthcare sector, stakeholders must navigate this terrain thoughtfully, leveraging technology and education to harness the benefits of genetic testing.

With the business in a tailspin, 23andMe’s CEO assures investors there’s still plenty of money it can make on your genes.

Pain and vision loss are late symptoms of periocular melanoma, and there are amelanotic variants.

Findings of what is supposed to be recreational genetic testing should not be used to make decisions about life insurance, according to one Delaware lawmaker.

/PRNewswire/ -- According to Ariztons latest research report, the U.S. clinical laboratory tests market will grow at a CAGR of 2.17% from 2023 to 2029. To...